Biofrontera Inc.
Biofrontera Inc. (BFRIW) Company Profile & Overview
Explore Biofrontera Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Biofrontera Inc. (BFRIW) Company Profile & Overview
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.